Submitted by Anonymous (not verified) on 25 July 2025 - 14:59
Human medicines European public assessment report (EPAR): Tezspire, tezepelumab, Date of authorisation: 19/09/2022, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tezspire, tezepelumab, Date of authorisation: 19/09/2022, Revision: 12, Status: Authorised